Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma. | Oxid Med Cell Longev | 2022 | 35096270 | PubTator, text mining | PubMed |
| HHLA2 Immune Checkpoint Is a Novel Prognostic Predictor in Hepatocellular Carcinoma. | Am J Clin Pathol | 2022 | 35084443 | PubTator, text mining | PubMed |
| Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma. | Oxid Med Cell Longev | 2022 | 35069971 | PubTator, text mining | PubMed |
| Biomarkers for predicting the efficacy of immune checkpoint inhibitors. | J Cancer | 2022 | 35069896 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis. | Biochem Biophys Rep | 2022 | 35059509 | PubTator, text mining | PubMed |
| Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight. | Cancers (Basel) | 2022 | 35053430 | PubTator, text mining | PubMed |
| The Immune Landscape of Hepatitis B Virus-Related Acute Liver Failure by Integration Analysis. | J Immunol Res | 2022 | 35036448 | PubTator, text mining | PubMed |
| ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma. | Can J Gastroenterol Hepatol | 2022 | 35028302 | PubTator, text mining | PubMed |
| miR-4759 suppresses breast cancer through immune checkpoint blockade. | Comput Struct Biotechnol J | 2022 | 35024096 | PubTator, text mining | PubMed |
| Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies. | Clin Exp Immunol | 2022 | 35020853 | PubTator, text mining | PubMed |
| Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer. | Int J Gen Med | 2022 | 35018112 | PubTator, text mining | PubMed |
| The B7H4-PDL1 classifier stratifies immuno-phenotype in cervical cancer. | Cancer Cell Int | 2022 | 34983532 | PubTator, text mining | PubMed |
| Soluble PD-L1 and B7-H4 serum levels during the course of physiological pregnancy. | Am J Reprod Immunol | 2022 | 34974633 | PubTator, text mining | PubMed |
| Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review. | Mol Diagn Ther | 2022 | 34957535 | PubTator, text mining | PubMed |
| Immunotoxicity and uterine transcriptome analysis of the effect of zearalenone (ZEA) in sows during the embryo attachment period. | Toxicol Lett | 2022 | 34933075 | PubTator, text mining | PubMed |
| Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors. | MAbs | 2022 | 34923919 | PubTator, text mining | PubMed |
| Expression of B7 family checkpoint proteins in cervical cancer. | Mod Pathol | 2022 | 34848831 | PubTator, text mining | PubMed |
| Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors. | Cancer Med | 2022 | 34841742 | PubTator, text mining | PubMed |
| B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression. | Oncogene | 2022 | 34839353 | PubTator, text mining | PubMed |
| Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens. | Cancer Immunol Immunother | 2022 | 34821951 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=49